Source comparison
Sermorelin Muscle Growth Results Timeline Expect: Comparison
Weeks 1–4 GH pulse frequency increases 40–60%; IGF-1 rises 10–15% Minimal; possible 0.5–1% body fat reduction None measurable by DEXA or caliper Improved sleep quality; faster inter-set recovery Hormonal priming phase. No visible muscle gains yet, but metaboli
This comparison does not assign a generated winner or score.
- Weeks 1–4
- GH pulse frequency increases 40–60%; IGF-1 rises 10–15%
- Minimal; possible 0.5–1% body fat reduction
- None measurable by DEXA or caliper
- Improved sleep quality; faster inter-set recovery
- Hormonal priming phase. No visible muscle gains yet, but metabolic foundation is being established
- Weeks 5–12
- IGF-1 elevation peaks at 30–50% above baseline; sustained nocturnal GH pulses
- 1.5–2.5% body fat reduction; 0.3–0.8 kg lean mass (mostly water/glycogen)
- Satellite cell activation begins; no fiber hypertrophy yet
- Strength gains 3–8% on compound lifts; reduced DOMS duration
- Early recomposition visible in waist circumference. Muscle hypertrophy hasn't started because myonuclear accretion lags IGF-1 by 8–12 weeks
- Months 3–6
- IGF-1 stable at elevated plateau; GH receptor sensitivity maintained
- 1.2–2.8 kg lean mass gain; continued fat loss (visceral adipose preferentially)
- Type II fibers show 8–15% cross-sectional area increase; myonuclear domain expansion confirmed
- Strength increases 8–15%; muscle endurance improves noticeably
- The sermorelin muscle growth results timeline expect inflection point. Visible hypertrophy emerges as satellite cells fuse and contractile protein synthesis accelerates
- Months 7–12
- IGF-1 remains elevated but gains slow unless dose adjusted
- Additional 1.5–3.0 kg lean mass (cumulative 3–6 kg total); plateau risk after month 10
- Progressive fiber thickening; gains concentrate in trained muscle groups
- Strength continues rising if training volume increases
- Peak anabolic window. Gains plateau around month 9–10 unless progressive overload continues; sermorelin amplifies training stimulus but doesn't replace it
- Beyond 12 months
- Diminishing returns without cycling or dose modulation
- Maintenance of gained mass; minimal new hypertrophy
- Gains stabilize; myonuclear permanence allows rapid regain after detraining
- Performance plateaus unless training variables change
- Long-term maintenance phase. Muscle gains persist if training continues, but new hypertrophy slows significantly without protocol adjustments